CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −32,789 | 92,763 | ||
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Option exercise | +5,700 | $1.41 | $8K | 56,733 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Sale | −5,600 | $17.28 | $97K | 51,133 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Sale | −100 | $18.09 | $2K | 51,033 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −5,700 | 125,552 | ||
| 2024-11-20 | Jewell Christopher M Chief Scientific Officer | Option exercise | +14,000 | $3.23 | $45K | 39,940 |
| 2024-11-20 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −14,000 | 76,432 | ||
| 2024-11-19 | Kurtoglu Metin Chief Technology Officer | Option exercise | +200 | $1.41 | $282 | 51,233 |
| 2024-11-19 | Kurtoglu Metin Chief Technology Officer | Sale | −200 | $19.50 | $4K | 51,033 |
| 2024-11-19 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −200 | 131,252 | ||
| 2024-11-19 | Singer Michael Director | Gift | −28,821 | 90,933 | ||
| 2024-11-18 | SPRINGER TIMOTHY A Director | Purchase | +38,114 | $17.96 | $684K | 8,435,525 |
| 2024-11-18 | SPRINGER TIMOTHY A Director | Purchase | +20,181 | $18.42 | $372K | 8,455,706 |
| 2024-11-18 | Kurtoglu Metin Chief Technology Officer | Option exercise | +34,400 | $1.41 | $49K | 85,433 |
| 2024-11-18 | Kurtoglu Metin Chief Technology Officer | Sale | −16,672 | $18.19 | $303K | 68,761 |
| 2024-11-18 | Kurtoglu Metin Chief Technology Officer | Sale | −17,728 | $18.58 | $329K | 51,033 |
| 2024-11-18 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −34,400 | 131,452 | ||
| 2024-11-15 | SPRINGER TIMOTHY A Director | Purchase | +277,246 | $17.09 | $4.7M | 8,397,411 |
| 2024-11-15 | Kurtoglu Metin Chief Technology Officer | Option exercise | +22,068 | $1.41 | $31K | 73,101 |
| 2024-11-15 | Kurtoglu Metin Chief Technology Officer | Sale | −22,068 | $17.20 | $379K | 51,033 |
Page 7 of 16 · 316 trades